Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across...
Growth Parameters |
---|
9 yrs | 5 yrs | 3 yrs | 1 yr | |
---|---|---|---|---|
Net Sales | 9.9% | 3.1% | 7.3% | 13.4% |
Adjusted EPS | 8.3% | -1.8% | 15.2% | 8.5% |
Book Value per Share | 16.5 | 10.2 | 8.3 | 11 |
Share Price | 13.3% | 13% | 26.9% | 66.1% |
Key Financial Parameter |
---|
Entity | Percentage Holding |
---|---|
Promoters | 26.73% |
Institutions | 43.86% |
Non-Institutions | 29.41% |
Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MoneyWorks4Me analysed the past 10-year performance of Dr. Reddys Laboratories Ltd and arrived at the following conclusion:
Past 10 year's financial track record indicates that Dr. Reddys Laboratories Ltd is a good quality company. However, for specific investment actions please connect with your investment advisor.The 5-year analysis of Dr. Reddys Laboratories Ltd's performance infers:
Dr. Reddys Laboratories Ltd earnings have declined by -1.8%, whereas share price has appreciated 13% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.We analysed the performance of Dr. Reddys Laboratories Ltd share prices over the last 10 years. Here is what we found out:
Dr. Reddys Laboratories Ltd share price has appreciated 11.9% annually over the past ten years.Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company’s shares trade on the Bombay Stock Exchange and the National Stock Exchange in India and on the New York Stock Exchange in the United States.
Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company’s shares trade on the Bombay Stock Exchange and the National Stock Exchange in India and on the New York Stock Exchange in the United States.
Business area of the company
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Products
Core Businesses
Pharmaceutical services & active ingredients
Global Generics
Proprietary Products
Awards & Recognitions
Milestones